Source Multiple Sclerosis News Today: Merck KGaA presented new evidence supporting the safety and clinical efficacy of Rebif (interferon beta-1a) for relapsing-remitting multiple sclerosis (RRMS) at the 5th Congress of the European Academy of Neurology (EAN), June 29–July 2 in Oslo, Norway.
Rebif Cost-effective and Can Reduce Brain Lesions in RRMS Patients, Data Show Read More »
Led by the University of Plymouth and published today in The Lancet Neurology, the study in people with progressive MS also showed that the intervention appeared cost-effective, leading researchers to conclude that it could be routinely implemented within MS care throughout the UK.
Source King’s College London: My name is Zara and I’m a research assistant from King’s College London. We are currently conducting a study investigating attention and fatigue in MS. Fatigue is a debilitating part of the MS experience and we hope that this research will help to create more understanding in this area for the development of
Research project – Attention and Fatigue in MS Read More »
Source UCLH.nhs.uk: UCLH’s Biomedical Research Centre has supported the development of a new artificial intelligence-based method for detecting the brain’s response to treatment in multiple sclerosis (MS) that is substantially better than what a human expert is able to do using conventional techniques, representing potentially ‘superhuman’ performance in the task.
Researchers devise AI-based method of detecting response to MS Read More »
Source Science Daily: Researchers have found mutations in 12 genes believed to be largely responsible for the onset of multiple sclerosis in families with multiple members diagnosed with the disease.
Scientists edge closer to root causes of multiple sclerosis Read More »
Source Multiple Sclerosis News Today: A subset of stem cells in hair follicles, called melanocytes, appear to do more than just give rise to mature melanocytes, cells that help to determine hair colour. Those melanocyte stem cells, or McSCs, that carry the CD34 protein were found in hair follicles from mice to differentiate into glial cells and
Source MS Society: Small but mighty, mitochondria provide the energy that busy nerve cells need to survive. We spoke with mitochondria expert Dr Don Mahad, from the University of Edinburgh, about what makes them so special – and what goes wrong in MS. Mitochondria and progressive MS ‘I’m interested in energy production and demand in the
Mitochondria and progressive MS Read More »
Source MS Trust: NICE will be assessing Plegridy to decide whether it should continue to be prescribed by the NHS in England. We’ll be telling NICE why we think it should be an option. If you are taking Plegridy we’d really like to know what you think of it, your experiences good and bad.
Anyone taking Plegridy? Read More »
Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS).
Source Multiple Sclerosis News Today: T20K, Cyxone‘s lead compound for treating multiple sclerosis (MS), seems able to prevent or slow disease progression, according to data from preclinical studies. Based on these findings, the company is confident that T20K might become a prophylactic (preventive) medication for MS in the near future.
T20K in Good Position to Become Preventive MS Treatment, Cyxone Says Read More »
